Health
New seaweed extract shows promising anti-inflammatory and gut health benefits
A NEW seaweed extract could have a positive impact on mental health and wellbeing, according to scientists testing it as part of efforts to improve the nation’s health.
Sourced from seaweed sustainably harvested in the UK, it could offer a new natural remedy for gut health ailments. Seaweed is considered to be a “superfood”, due to its high fibre, amino acids, vitamins and minerals.
Long recognised in Asia for its therapeutic potential, the seaweed extract fucoidan is now attracting growing interest elsewhere in the world as demand rises for natural compounds with proven health benefits.
The 12-month INNOSea study focused on producing and trialling a purified extract of fucoidan, marketed as Thalivra, which showed promising effects on digestive health and overall wellbeing.

The first 28-day clinical trial suggested improvements in the mental wellbeing of young adults. The results pave the way for larger-scale testing.
Scientists at Aberystwyth University’s Department of Life Sciences, alongside researchers at the Institute of Biological, Environmental and Rural Sciences (IBERS) and seaweed ingredient technology company BioMara, developed and conducted the work.
Dr Jessica Adams, a seaweed expert from IBERS at Aberystwyth University, said: “Many people will have heard of the health and dietary benefits of seaweed – these tests add to that evidence. From a processing and bioactivity standpoint, the data from our study is striking. Achieving food-grade fucoidan at scale with such a potent anti-inflammatory profile is a real breakthrough. It opens the door for Thalivra to be positioned not just as a safe ingredient, but as one with genuine functional potential in gut health and immune-support formulations.”
The human trial was led by Dr Amanda J Lloyd and Dr Alina Warren-Walker from the Department of Life Sciences at Aberystwyth University. Dr Lloyd added: “This was the first time BioMara’s seaweed extract has been tested in humans, and the results are very encouraging. Participants tolerated the supplement extremely well, and we observed early trends in mental wellbeing that deserve further study. Importantly, the strong safety and retention profile gives us confidence to scale up into larger and different groups, and for longer trial periods.”
The project was funded by Innovate UK and BBSRC as part of a £2.5 million investment in 13 projects to drive the design and development of innovative food and beverage products.
Jay Dignan, Founder and CEO of BioMara, said: “Completing INNOSea marks a turning point. We’ve proven that Thalivra can be produced at scale, is safe for daily use, and shows compelling anti-inflammatory and wellbeing trends. This lays the foundation for larger clinical trials and, ultimately, commercial partnerships to bring Thalivra into gut health and immune-support formulations in a fast-growing global market.”
Thalivra fucoidan is harvested in Scottish waters and processed into a powder using BioMara’s unique method. It is approved for use as a novel food.
Health
£23m investment to expand medicine production in Wales and create new jobs
Pharmaceutical firm Norgine to grow Hengoed facility as government promotes global trade push
A £23 MILLION investment in pharmaceutical manufacturing in South Wales is set to create 44 new jobs and expand production of essential medicines.
The investment will see European pharmaceutical company Norgine increase warehousing and production capacity at its manufacturing facility in Hengoed, Caerphilly.
The expansion was announced on Thursday (Mar 5) by Secretary of State for Wales Jo Stevens, who visited the site to mark the development.
The project has been supported by the UK Government’s Life Sciences Innovative Manufacturing Fund (LSIMF), part of a wider strategy to strengthen the UK’s health sector and domestic medicine supply.
The £520 million fund aims to attract innovative pharmaceutical manufacturing projects and improve the resilience of medicine supply chains across the UK.
The Welsh life sciences sector continues to grow rapidly. Latest figures show it generated more than £3.5 billion in turnover and supported over 13,000 jobs across more than 280 companies in 2023/24.
The Hengoed facility forms part of a South Wales life sciences cluster identified in the UK Government’s Life Sciences Sector Plan as an area of particular strength.
International investment push
The announcement also coincided with the launch of a new programme designed to promote Welsh trade and investment internationally.
At the Wales Office St David’s Day reception held at Wolf Studios in Cardiff, Jo Stevens confirmed the government will begin a series of overseas initiatives aimed at attracting further international investment into Wales.
The programme will include targeted trade missions to key markets, closer collaboration with the Welsh Government and local partners, and a new fund allowing UK embassies and overseas offices to specifically promote investment opportunities in Wales.
Minister welcomes expansion
The Secretary of State for Wales, Jo Stevens said: “We have a thriving life sciences sector in Wales, and this investment from Norgine is a vote of confidence in our Welsh workforce.
“I am delighted that UK Government funding is supporting the business to continue to grow and create new well-paid jobs.
“Norgine is a brilliant example of an international business that is flourishing in Wales. With our new international programme we are going to build on successes like this to attract even more investment that will create opportunities across the country.”
Company highlights Welsh roots
Janneke van der Kamp, Chief Executive Officer of Norgine, said the investment marked an important milestone for the company and its Welsh operations.
“We have a proud 60-year manufacturing heritage in Wales, and this investment will strengthen our ability to reliably supply essential medicines while creating high-quality jobs for the future,” she said.
“We are deeply committed to Wales, not only through our manufacturing footprint but also through developing local talent in partnership with Cardiff University and regional colleges.”
The UK Government said Wales continues to attract strong levels of international investment, accounting for nearly five percent of all inward investment projects across the UK, creating more than 2,000 jobs in 2024/25 alone.
Health
Accidental poisoning deaths surge in Wales as elderly face growing risk
Nearly 200% rise in five years raises alarm among safety experts
ACCIDENTAL poisoning deaths in Wales have surged dramatically, with new safety data showing a sharp increase in fatalities and a growing risk to older people living at home.
Figures released by the Royal Society for the Prevention of Accidents (RoSPA) show 252 people in Wales died from accidental poisoning in 2024, compared with 85 deaths in 2019 – an increase of almost 200 per cent in just five years.
Safety experts say older people are particularly vulnerable. Those aged 65 and over are more than five times more likely to die from an accidental poisoning – excluding narcotics – than the general population.
Even when alcohol-related incidents are excluded, people in this age group remain more than four times as likely to die from accidental poisoning.
Across the UK the trend is also rising sharply. Official figures show 5,770 people died from accidental poisonings in 2024, a 63 per cent increase over the past decade.
Hospitals in England recorded 17,252 admissions linked to non-narcotic poisoning last year, including nearly 5,000 cases involving older adults, who were 55 per cent more likely to require emergency hospital care.
RoSPA warns that people living with dementia face particular dangers inside their own homes because the condition can affect memory, recognition and perception. Everyday household products such as cleaning sprays, laundry detergents and medicines can easily be mistaken for food or drink.
Rebecca Guy, Senior Policy Manager at RoSPA, said: “Families caring for vulnerable relatives can experience genuinely frightening moments. Turning away for just a few seconds and realising someone has swallowed a cleaning product is sadly something some people have experienced.
“These incidents are not freak accidents. They are predictable and preventable events, and our new guidance is designed to help people take simple steps to make their homes safer.”
The charity has released new home-safety guidance aimed at helping families reduce risks, including practical advice on safely storing medicines and household chemicals.
Paul Edwards, Chief Nursing Officer at Dementia UK, said brightly coloured packaging on cleaning products can create confusion for people living with dementia.
“Laundry and cleaning products are often easily accessible in our homes, and many have brightly coloured packaging which can cause confusion for people with dementia, who may mistake them for edible items,” he said.
“One of the challenges of supporting someone with dementia is balancing an individual’s independence with their safety. It is impossible to eliminate risk completely, but these guidelines offer simple steps people can take to reduce the chance of these accidents happening.”
Simon Wheeler, Senior Knowledge Officer at Alzheimer’s Society, said staying safe at home is a key concern for families affected by dementia.
“As dementia progresses, people may find it harder to tell the difference between something that’s safe to eat and something that isn’t,” he said.
“Storing cleaning products safely and out of sight can help reduce the risk of accidents.”
RoSPA is urging households to take simple precautions, including locking away cleaning products, keeping medicines securely stored, and ensuring hazardous substances remain in their original packaging.
Safety experts warn that without greater awareness, accidental poisonings could continue to rise as the population ages and more people live independently at home.
Business
Crymych golf simulator, play space and wellness centre call
A CALL for approval for the use of Crymych industrial units as a golf simulator, child’s play space and a wellness centre offering a sauna, ice baths, and oxygen therapy has been submitted to county planners.
In an application to Pembrokeshire County Council, Mr and Mrs Evans, through agent Preseli Planning Ltd, seek a partly retrospective permission for the erection of commercial building containing three individual business units, at a former vacant storage yard at Parc Gwynfryn, Crymych.
A supporting statement says: “The building provides three sperate business spaces, two of the units are occupied, one as a golf simulator (7B 2) a second is occupied by a child’s role play and play space (7B 4) and the central unit (7B 3) is currently unoccupied, proposed to be let as a wellness centre.”
The site owners and applicants, Mr and Mrs Evans, are also the operators of the golf simulator enterprise and the original developers of the industrial estate, the statement says.
“The aim of the application is to regularise the existing building and existing and proposed uses. The building was substantially complete May 2025 and first occupied June 2025. Unit 7B2 is occupied by a golf simulator whereby users book slots online and self-serve.
“Unit 7B3 is currently unoccupied but would be occupied by wellness centre once planning permission is granted, consisting of sauna, ice baths, cryotherapy room, oxygen therapy etc. Unit 7B4 is occupied by a new enterprise which offers indoor roleplay space for children, Byd Bach.”
It adds: “In terms of the golf simulator, this is owner managed and the sites proximity to their main office within the site makes managing and attending the unit convenient and enables multiple businesses to be managed by the same members of staff.
“In terms of Byd Bach, this is operated by a local couple who also manage other premises in Crymych, amongst other employment. The site’s proximity to Crymych is therefore important and these arrangements are only successful given that the site is well-related to Crymych.
“The offering would not disrupt existing comparable provision, the closest facility of this kind being in St Clears, well beyond the catchment of this facility.
“The third unit is not yet occupied but would be operated by a local spinal injury sufferer, and athlete, who would benefit from the facilities themselves and offer therapy for others.”
Citing a recently-approved change on use of a building on the industrial site itself to a Hair and Beauty Salon, it said it was considered the development would not have a significant detrimental effect on the overall supply of business units or land in Pembrokeshire or Crymych.
The application will be considered by county planners at a later date.
-
News7 days agoHoax 999 call sparks massive lifeboat and helicopter rescue — man arrested
-
Crime7 days agoWest Wales man jailed for murder of five-month-old baby
-
Entertainment7 days agoYouth theatre production supported by Pembrokeshire Coast National Park Authority
-
Health7 days agoWho is responsible for NHS changes affecting west Wales?
-
Farming7 days agoHigher welfare farming benefits millions of animals in Wales
-
Crime7 days agoPembroke Dock man admits sending sword death threat message
-
Crime7 days agoHaverfordwest woman banned from road after second drink-drive conviction
-
Business7 days agoPembroke Power Station marks 10,000th turbine start









